Abstract
Molecular point-of-care (POC) testing is defined as the diagnostic testing of acute-care parameters at or close to the patients „bed side" [1]. The development of POC technologies and platforms aims to speed up diagnosis time to start targeted therapeutic treatments without a lag in time caused by the transport of samples to external laboratories as well as lengthy analytical methods. This article describes an enabling approach based on reversed purification of nucleic acids resulting in a fast sample analysis and a miniaturized disposable sample cartridge.
This is a preview of subscription content, log in via an institution to check access.
Literatur
Kost GJ (2002) Principles and Practice of Point-of-Care Testing. Lippincott Williams & Wilkins, Hagerstown, MD
Cassini A, Plachouras D, Eckmanns T et al. (2016) Burden of Six Healthcare-Associated Infections on European Population Health: Estimating Incidence-Based Disability-Adjusted Life Years through a Population Prevalence-Based Modelling Study. PLOS Med, https://doi.org/10.1371/journal.pmed.1002150
Peter H, Berggrav K, Thomas P et al. (2012) Direct detection and genotyping of Klebsiella pneumoniae carbapene-mases from urine by use of a new DNA microarray test. J Clin Microbiol 50:3990–3998
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Müller, M. Miniaturisierung von diagnostischen point-of-care-Plattformen. Biospektrum 25, 538–540 (2019). https://doi.org/10.1007/s12268-019-0194-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12268-019-0194-z